Atrovent

DRUG3 trials

Sponsors

Boehringer Ingelheim, Wake Forest University Health Sciences

Conditions

COPDCOPD ExacerbationPulmonary Disease, Chronic Obstructive

Phase 3

Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease

CompletedNCT02172443

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2001-06-30Updated: 2018-08-31

Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease

CompletedNCT02177344

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 1998-08-31Updated: 2014-07-17

Phase 4

Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)

TerminatedNCT03219866

Wake Forest University Health SciencesCOPD, COPD Exacerbation

Start: 2017-10-03End: 2020-04-01Updated: 2021-06-22